Earnings Preview: Arcturus Therapeutics (ARCT) Q1 Earnings Expected to Decline

  • Arcturus Therapeutics (ARCT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.